Results 141 to 150 of about 7,551 (201)

Efficacy of NAs in combination with Peg-IFN for functional cure in patients with CHB: a meta-analysis of RCTs. [PDF]

Ann Med
Zhang Y, Zhang Z, Li X, Cao W, Wang S, Deng W, Wei X, Yao L, Xie Y, Li M.   +9 more
europepmc   +1 more source

Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]

Front Med (Lausanne)
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc   +1 more source

Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. [PDF]

Infect Drug Resist
Xia S, He X, Gan J, Ding J.
europepmc   +1 more source

Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure. [PDF]

Med Sci Monit, 2019
Chen Q, Zhang J, Huang J, Quan B, Wu X, Deng S, Han W.   +6 more
europepmc   +1 more source

Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. [PDF]

J Clin Transl Hepatol
Liu L, Xu Q, Lin S, Wei Z, Huang G.
europepmc   +1 more source

Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis. [PDF]

J Clin Transl Hepatol
Zhang Y, Wang LF, Chen J, Nguyen MH, Zheng Q.   +4 more
europepmc   +1 more source

Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study. [PDF]

Front Cell Infect Microbiol
Wang XH, Chang YN, Zhang L, Yang YL, Liang LW, Zeng Y, Zhou Z, Zhong S, Li H.   +8 more
europepmc   +1 more source

Correction for Suzuki et al., "Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion". [PDF]

J Clin Microbiol
Suzuki T, Ohue C, Arai O, Inose Y, Nagaoka K, Ogawa S, Inoue T, Matsuura K, Aoyagi K, Yagi S, Tanaka Y.   +10 more
europepmc   +1 more source

Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection. [PDF]

Drug Des Devel Ther
Zhang Y, Li Y, Lian JQ, Kang W.
europepmc   +1 more source

Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study. [PDF]

Virol J
Zhang W, Chen J, Sun W, Xie N, Tian F, Zhang W, Ruan Q, Song J.   +7 more
europepmc   +1 more source